FDA Authorizes Pfizer Pill to Treat Covid-19 in High-Risk Patients

Se espera que unos 65,000 tratamientos de Paxlovid se distribuyan en los próximos días.

Some 65,000 Paxlovid treatments are expected to be distributed in the next few days.

Photo: JOHN THYS / AFP / Getty Images

The work of big pharma throughout the Covid pandemic It has not only focused on creating effective vaccines against this virus and its variants, but also on finding the right drug to treat patients who have contracted the disease and who for various reasons could develop complications that could become fatal.

Pfizer is one of the laboratories that for months has been working on the development of an effective drug and capable of controlling the infection caused by contracting Covid-19, thus developing the Paxlovid pill, which according to various studies carried out in previous months, showed to have an 89% reduction in hospitalization of the patients who were treated with this medicine within 3 days after the development of the symptoms, compared with the patients who received other treatments. Furthermore, none of the patients treated with the drug died.

Too, Pfizer stated that recent studies found their pill to be highly effective in patients infected with the Omicron variant as well..

Given the current situation due to the variant Ómicron, which has again accelerated the growth in the number of infections and thinking of avoiding a possible collapse in medical services, this Wednesday, the Food and Drug Administration of the United States (FDA, for its acronym in English) announced its Authorization of the use of Pfizer’s anti-Covid pills in coronavirus patients.

The FDA indicated that the pill from Pfizer (Paxlovid) should be given to Covid patients over 12 years of age who are vulnerable to becoming seriously ill because of their age or because they have certain medical conditions, such as obesity or diabetes. He also clarified that both vaccinated and unvaccinated may be eligible to be treated with this drug in case of infection with the virus.

Similarly, the FDA clarified that the decision was made thinking that there are patients who can be treated at home, without the need to go to the hospital, which will lower the burden of care at a time when a significant increase in the number of patients is expected. number of positive cases.

Paxlovid treatment consists of taking 30 pills for 5 days, accompanied by another medicine called ritonavir, which is often used in patients with HIV and helps the Pfizer medicine stay active in the body longer.

The US Government ordered 10 million complete treatments of the pill from Pfizer, which will cost approximately $ 530 per patient. The pharmaceutical company also indicated that in these first days, the supply will be somewhat limited since they will only be able to distribute treatments for around 65,000 patients; but they are expected to deliver about 200,000 in January and another 150,000 in February 2022.

It may interest you:

* Microchip implanted in your arm could track the status of your Covid vaccine with just one scan
* AstraZeneca and Oxford began work on a vaccine against the Omicron variant
* The US could reduce the quarantine of 10 days to those infected by Omicron for those vaccinated, says Fauci


See also  How getting more sleep can help you lose weight

Leave a Comment

Your email address will not be published.